As with any therapeutic intervention, individualized assessment, clear patient communication, and systematic monitoring remain essential
Insurance companies sometimes deny first requests as a default strategy, knowing that many patients give up
Retatrutide is a novel triple receptor agonist peptide developed by Eli Lilly that simultaneously targets the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R)
Handling & storage Store refrigerated at 28C and protect from light
When alcohol is consumed, the liver prioritizes metabolizing alcohol over maintaining blood glucose, increasing the risk of hypoglycemia, especially in individuals with diabetes
Diabetes Obes Metab 2020;22:631-9